BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 15292336)

  • 1. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia.
    Takeuchi Y; Suzuki H; Ogura S; Imai R; Yamazaki Y; Yamashita T; Miyamoto Y; Okazaki H; Nakamura K; Nakahara K; Fukumoto S; Fujita T
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3979-82. PubMed ID: 15292336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
    BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.
    Yamazaki Y; Okazaki R; Shibata M; Hasegawa Y; Satoh K; Tajima T; Takeuchi Y; Fujita T; Nakahara K; Yamashita T; Fukumoto S
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4957-60. PubMed ID: 12414858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.
    Shimada T; Mizutani S; Muto T; Yoneya T; Hino R; Takeda S; Takeuchi Y; Fujita T; Fukumoto S; Yamashita T
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6500-5. PubMed ID: 11344269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23.
    Nasu T; Kurisu S; Matsuno S; Tatsumi K; Kakimoto T; Kobayashi M; Nakano Y; Wakasaki H; Furuta H; Nishi M; Sasaki H; Suzuki H; Ito N; Fukumoto S; Nanjo K
    Intern Med; 2008; 47(10):957-61. PubMed ID: 18480582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
    Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.
    Endo I; Fukumoto S; Ozono K; Namba N; Tanaka H; Inoue D; Minagawa M; Sugimoto T; Yamauchi M; Michigami T; Matsumoto T
    Bone; 2008 Jun; 42(6):1235-9. PubMed ID: 18396126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment of assay system for fibroblast growth factor (FGF)-23 and pathophysiological roles of FGF-23 in the development of hypophosphatemic diseases].
    Fukumoto S; Nakahara K
    Rinsho Byori; 2004 Jan; 52(1):51-4. PubMed ID: 14968560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in the management of tumor-induced osteomalacia (TIO).
    Brandi ML; Clunie GPR; Houillier P; Jan de Beur SM; Minisola S; Oheim R; Seefried L
    Bone; 2021 Nov; 152():116064. PubMed ID: 34147708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cinacalcet in the management of tumor-induced osteomalacia.
    Geller JL; Khosravi A; Kelly MH; Riminucci M; Adams JS; Collins MT
    J Bone Miner Res; 2007 Jun; 22(6):931-7. PubMed ID: 17352646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
    Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
    Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature.
    Jiang Y; Xia WB; Xing XP; Silva BC; Li M; Wang O; Zhang HB; Li F; Jing HL; Zhong DR; Jin J; Gao P; Zhou L; Qi F; Yu W; Bilezikian JP; Meng XW
    J Bone Miner Res; 2012 Sep; 27(9):1967-75. PubMed ID: 22532501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Jonsson KB; Zahradnik R; Larsson T; White KE; Sugimoto T; Imanishi Y; Yamamoto T; Hampson G; Koshiyama H; Ljunggren O; Oba K; Yang IM; Miyauchi A; Econs MJ; Lavigne J; Jüppner H
    N Engl J Med; 2003 Apr; 348(17):1656-63. PubMed ID: 12711740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor induced osteomalacia: associated with elevated circulating levels of fibroblast growth factor-7 in addition to fibroblast growth factor-23.
    Bansal S; Khazim K; Suri R; Martin D; Werner S; Fanti P
    Clin Nephrol; 2016 Jan; 85(1):57-62. PubMed ID: 26521888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reports of 17 Chinese patients with tumor-induced osteomalacia.
    Yu WJ; He JW; Fu WZ; Wang C; Zhang ZL
    J Bone Miner Metab; 2017 May; 35(3):298-307. PubMed ID: 27085966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia.
    Fukumoto S; Takeuchi Y; Nagano A; Fujita T
    Bone; 1999 Sep; 25(3):375-7. PubMed ID: 10495143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin.
    Fukumoto S; Yamashita T
    Curr Opin Nephrol Hypertens; 2002 Jul; 11(4):385-9. PubMed ID: 12105387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative tumor localization by means of venous sampling for fibroblast growth factor-23 in a patient with tumor-induced osteomalacia.
    Westerberg PA; Olauson H; Toss G; Wikström B; Morales O; Linde T; Jonsson K; Ljunggren O; Larsson TE
    Endocr Pract; 2008 Apr; 14(3):362-7. PubMed ID: 18463045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypophosphatemic osteomalacia].
    Bullmann C; Benker G; Rosien U; Delling G; Siggelkow H; Schulte HM
    Med Klin (Munich); 2008 Sep; 103(9):671-5. PubMed ID: 18813890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-induced osteomalacia originating from the temporal bone: a case report.
    Kobayashi K; Nakao K; Kawai K; Ito K; Hukumoto S; Asakage T; Oota S; Motoi R
    Head Neck; 2011 Jul; 33(7):1072-5. PubMed ID: 20146335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.